Spyre Therapeutics, Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

15.65

-0.55 (-3.40%)

At close: Sep 12, 2025, 4:00 PM EDT

15.66

+0.01 (0.06%)

After-hours: Sep 12, 2025, 5:27 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2017 - 2018
Biopharmaceutical Products	886.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceutical Products Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2017 - 2018
United States	886.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade